⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Safety Study of SGN-CD19A for Leukemia and Lymphoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Safety Study of SGN-CD19A for Leukemia and Lymphoma

Official Title: A Phase 1, Open-Label, Dose-Escalation Study of SGN-CD19A in Patients With B-Lineage Acute Lymphoblastic Leukemia and Highly Aggressive Lymphomas

Study ID: NCT01786096

Interventions

SGN-CD19A

Study Description

Brief Summary: This is a phase 1, open-label, dose-escalation, multicenter study to evaluate the safety and tolerability of SGN-CD19A in adult and pediatric patients with relapsed or refractory B-lineage acute lymphoblastic leukemia (B-ALL), Burkitt lymphoma or leukemia, or B-lineage lymphoblastic lymphoma (B-LBL).

Detailed Description:

Eligibility

Minimum Age: 1 Year

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Children's Hospital of Alabama / University of Alabama at Birmingham, Birmingham, Alabama, United States

University of Alabama at Birmingham, Birmingham, Alabama, United States

Mayo Clinic Arizona, Scottsdale, Arizona, United States

City of Hope National Medical Center, Duarte, California, United States

Mayo Clinic Florida, Jacksonville, Florida, United States

All Children's Hospital, Saint Petersburg, Florida, United States

H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Children's Healthcare of Atlanta / Emory University, Atlanta, Georgia, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Boston Children's Hospital, Boston, Massachusetts, United States

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Contact Details

Name: Eric Feldman, MD

Affiliation: Seagen Inc.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: